Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I'll be soon....don't worry. Small MM hits bringing it down. Riding free shares and adding more now..
LOL! Too funny.........
LOL! Too funny....
LOL! Good to add here....
Thanks for the update!
Holding and will add to my ROTH more if it hits 5's. I'm in this long and not worried short term. I have RX in other accounts also.
We should be at $.30.........
Getting close John!!!!
$RXMD - PROFITS!!! Progressive Care Announces Record Earnings and Revenue for Three Months Ended March 31, 2021
BY GlobeNewswire
— 9:56 AM ET 05/18/2021
MIAMI, FL, May 18, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Progressive Care Inc. (“Progressive Care” or the “Company”), a personalized healthcare services and technology company, is pleased to announce the filing of the Company’s financial performance data setting new revenue and earnings records for the three months ended March 31, 2021.
“Our first quarter results exceeded expectations, driven by COVID-19 testing service demand and continued strong growth in third-party administrative services performed for 340B covered entities,” commented Alan Jay Weisberg, CEO and Chairman of Progressive Care ( RXMD
Loading...
Loading...
), “Our ClearMetrX data analytics platform is nearing completion and we expect to see business come online from pharmacies and medical practices over coming quarters.”
Financial Highlights for Quarter Ended March 31, 2021
Consolidated revenue for the quarter was $9.6 million, representing a year-over-year increase of 6% compared to Q1 2020
Adjusted EBITDA of $141 thousand, an increase of over $780k over the adjusted EBITDA from Q1 2020
Break even in cash flow from operating activities during Q1 2021
Increased cash position to over $2.4 million from December 31, 2020
Prescriptions filled during Q1 totaled approximately 116,000, representing a year-over-year decrease of 12% compared to Q1 2020
340B revenue contribution was approximately $724k, up 264% on a year-over-year basis when compared to Q1 2020
Revenues associated with COVID testing totaled approximately $550k for the quarter
Cecile Munnik, CFO stated, “We project that our testing services will remain at or above our present levels and expect to benefit from ongoing testing and vaccinations as travel restrictions are lifted. The rapid test model has proven to be very profitable. To capitalize on this proven model, we are looking to expand our testing to other illnesses, including STDs, testing for various allergies, woman’s health and more. Some of the tests will require our pharmacies to get additional licensing. Our compliance team is working diligently on getting all the regulatory information so we can put into action our ultimate goal to have a hybrid model that offers both Lab and Pharmacy services under one roof.”
Operational Highlights for Quarter Ended March 31, 2021
New Company record for Q1 performance in terms of both revenues and earnings
Expanded COVID-19 Rapid Testing to 7 days a week thereby maximizing our hours of operations
Completed relocations of PharmCo 901 and PharmCo 1103, providing expanded growth potential and access to a wider base of customers and providers
Expanded number of contracts for 340B pharmacy dispensing and TPA services
Received approval to administer Covid-19 vaccines to customers
Management notes that the 12% year-over-year decline in filled prescriptions was attributable to downtime related to relocation of pharmacy operations for PharmCo 901 and PharmCo 1103, and the implementation of a new pharmacy software platform. PharmCo 901 was moved from its former location at North Miami Beach to its new expanded 11,000 sq.ft location at Hallandale Beach, which necessitated a temporary closure of the North Miami Beach location prior to the opening of operations at Hallandale Beach. PharmCo 1103 was moved from a small location in Orlando to a much larger, 4,000 sq.ft location.
Management believes these factors represent temporary obstacles and anticipate that volume will pick back up during the remainder of 2021. Furthermore, the new locations for both PharmCo 901 and 1103 are expansions that we expect will allow for organic growth in core pharmacy operations. In conclusion, Mr. Weisberg added, “We believe that Q1 2021 has been a promising start to accomplishing each of the Company’s goals. As we progress through the year, it will be important to keep our management team’s vision for Progressive Care ( RXMD
Loading...
Loading...
) in mind. The healthier we make our patients, the more successful our business will be, and we will not lose sight of that vision, with the added goal of enhancing and creating more value for our shareholders.”
For more information about Progressive Care ( RXMD
Loading...
Loading...
), please visit the company’s website. Connect and stay in touch with us on social media:
Progressive Care Inc. ( RXMD
Loading...
Loading...
)
https://www.facebook.com/ProgressiveCareUS/
https://twitter.com/ProgressCareUS
PharmCoRx
https://www.facebook.com/pharmcorx/
https://twitter.com/PharmCoRx
ClearMetrX
https://www.clearmetrx.com/
https://www.facebook.com/clearmetrx/
About Progressive Care ( RXMD
Loading...
Loading...
): Progressive Care Inc. ( RXMD
Loading...
Loading...
) , through its subsidiaries, is a Florida health services organization and provider of prescription pharmaceuticals, compounded medications, provider of tele-pharmacy services, the sale of anti-retroviral medications, medication therapy management (MTM), the supply of prescription medications to long-term care facilities, and health practice risk management.
Cautionary Disclosure Regarding Forward-Looking Statements
Forward-Looking Statements contained herein that are not based upon current or historical fact are forward-looking in nature and constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Such forward-looking statements reflect the Company’s expectations about its future operating results, performance, and opportunities that involve substantial risks and uncertainties. When used herein, the words “anticipate,” “believe,” “estimate,” “upcoming,” “plan,” “target,” “intend” and “expect” and similar expressions, as they relate to Progressive Care Inc. ( RXMD
Loading...
Loading...
), its subsidiaries, or its management, are intended to identify such forward-looking statements. These forward-looking statements are based on information currently available to the Company and are subject to a number of risks, uncertainties, and other factors that could cause the actual results, performance, prospects, and opportunities to differ materially from those expressed in, or implied
$RXMD - PROFITS!!! Progressive Care Announces Record Earnings and Revenue for Three Months Ended March 31, 2021
BY GlobeNewswire
— 9:56 AM ET 05/18/2021
MIAMI, FL, May 18, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Progressive Care Inc. (“Progressive Care” or the “Company”), a personalized healthcare services and technology company, is pleased to announce the filing of the Company’s financial performance data setting new revenue and earnings records for the three months ended March 31, 2021.
“Our first quarter results exceeded expectations, driven by COVID-19 testing service demand and continued strong growth in third-party administrative services performed for 340B covered entities,” commented Alan Jay Weisberg, CEO and Chairman of Progressive Care ( RXMD
Loading...
Loading...
), “Our ClearMetrX data analytics platform is nearing completion and we expect to see business come online from pharmacies and medical practices over coming quarters.”
Financial Highlights for Quarter Ended March 31, 2021
Consolidated revenue for the quarter was $9.6 million, representing a year-over-year increase of 6% compared to Q1 2020
Adjusted EBITDA of $141 thousand, an increase of over $780k over the adjusted EBITDA from Q1 2020
Break even in cash flow from operating activities during Q1 2021
Increased cash position to over $2.4 million from December 31, 2020
Prescriptions filled during Q1 totaled approximately 116,000, representing a year-over-year decrease of 12% compared to Q1 2020
340B revenue contribution was approximately $724k, up 264% on a year-over-year basis when compared to Q1 2020
Revenues associated with COVID testing totaled approximately $550k for the quarter
Cecile Munnik, CFO stated, “We project that our testing services will remain at or above our present levels and expect to benefit from ongoing testing and vaccinations as travel restrictions are lifted. The rapid test model has proven to be very profitable. To capitalize on this proven model, we are looking to expand our testing to other illnesses, including STDs, testing for various allergies, woman’s health and more. Some of the tests will require our pharmacies to get additional licensing. Our compliance team is working diligently on getting all the regulatory information so we can put into action our ultimate goal to have a hybrid model that offers both Lab and Pharmacy services under one roof.”
Operational Highlights for Quarter Ended March 31, 2021
New Company record for Q1 performance in terms of both revenues and earnings
Expanded COVID-19 Rapid Testing to 7 days a week thereby maximizing our hours of operations
Completed relocations of PharmCo 901 and PharmCo 1103, providing expanded growth potential and access to a wider base of customers and providers
Expanded number of contracts for 340B pharmacy dispensing and TPA services
Received approval to administer Covid-19 vaccines to customers
Management notes that the 12% year-over-year decline in filled prescriptions was attributable to downtime related to relocation of pharmacy operations for PharmCo 901 and PharmCo 1103, and the implementation of a new pharmacy software platform. PharmCo 901 was moved from its former location at North Miami Beach to its new expanded 11,000 sq.ft location at Hallandale Beach, which necessitated a temporary closure of the North Miami Beach location prior to the opening of operations at Hallandale Beach. PharmCo 1103 was moved from a small location in Orlando to a much larger, 4,000 sq.ft location.
Management believes these factors represent temporary obstacles and anticipate that volume will pick back up during the remainder of 2021. Furthermore, the new locations for both PharmCo 901 and 1103 are expansions that we expect will allow for organic growth in core pharmacy operations. In conclusion, Mr. Weisberg added, “We believe that Q1 2021 has been a promising start to accomplishing each of the Company’s goals. As we progress through the year, it will be important to keep our management team’s vision for Progressive Care ( RXMD
Loading...
Loading...
) in mind. The healthier we make our patients, the more successful our business will be, and we will not lose sight of that vision, with the added goal of enhancing and creating more value for our shareholders.”
For more information about Progressive Care ( RXMD
Loading...
Loading...
), please visit the company’s website. Connect and stay in touch with us on social media:
Progressive Care Inc. ( RXMD
Loading...
Loading...
)
https://www.facebook.com/ProgressiveCareUS/
https://twitter.com/ProgressCareUS
PharmCoRx
https://www.facebook.com/pharmcorx/
https://twitter.com/PharmCoRx
ClearMetrX
https://www.clearmetrx.com/
https://www.facebook.com/clearmetrx/
About Progressive Care ( RXMD
Loading...
Loading...
): Progressive Care Inc. ( RXMD
Loading...
Loading...
) , through its subsidiaries, is a Florida health services organization and provider of prescription pharmaceuticals, compounded medications, provider of tele-pharmacy services, the sale of anti-retroviral medications, medication therapy management (MTM), the supply of prescription medications to long-term care facilities, and health practice risk management.
Cautionary Disclosure Regarding Forward-Looking Statements
Forward-Looking Statements contained herein that are not based upon current or historical fact are forward-looking in nature and constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Such forward-looking statements reflect the Company’s expectations about its future operating results, performance, and opportunities that involve substantial risks and uncertainties. When used herein, the words “anticipate,” “believe,” “estimate,” “upcoming,” “plan,” “target,” “intend” and “expect” and similar expressions, as they relate to Progressive Care Inc. ( RXMD
Loading...
Loading...
), its subsidiaries, or its management, are intended to identify such forward-looking statements. These forward-looking statements are based on information currently available to the Company and are subject to a number of risks, uncertainties, and other factors that could cause the actual results, performance, prospects, and opportunities to differ materially from those expressed in, or implied
PROFIT$$$$$$ I agree!
I'll take PROFITS! FULL STEAM AHEAD WITH THE S-1, MERGER, UPLIST!!!
I was happy he took questions! Still very confident here!
$RXMD - PROFITS!!!!!!!!!!!!!!!!!!
$RXMD - PROFITS!!!!!!!!!!!!!!!!!!!!!!!!!!!!
8's will be gone soon! Many waiting on this news!
Profits...cash! I like this!
PROFITS!
Looking good now! Feel much better! PROFITS!
Did I hear profits! YES!
I really think if they say profits for Q1 this will take off tomorrow!
LOL! Good for me!
You answers will hopefully come Monday....
My Thoughts Exactly!
It's called a quiet period!
I believe I bought a lot of shares around that timeframe! Nice Add!
Good Volume Already. Buying before the news and CC on Monday!
I really hope we see a PR Friday after hours or at least Monday morning like they usually do prior to a call.
If they announce profits, which I believe they will on Monday, its only up from here. Profits should get us at a stable minimum $.20PPS. Now if there is juicy news also in there...higher.
All that matters is how he is making RXMD GREAT AGAIN! Which he has been doing and still is!
Any Day now! Paytience!
This is the time to load up....
Games Again! Small bid hits to scare investors. Forest thru the Trees here! MM's will soon be crushed!
News Out! Thoughts on a PR Monday morning then the call in the afternoon?
NEWS OUT! THIS COULD BE THE DAY!! MIAMI, Fl -- May 12, 2021 -- InvestorsHub NewsWire -- via NewMediaWire -- Progressive Care Inc. (OTCQB: RXMD), a personalized healthcare services and technology company, is pleased to announce that the Company has scheduled an investor conference call at 4:30 PM ET on Monday, May 17, 2021.
“We are pleased with the results of the first quarter of 2021 and our business outlook generally. We believe that our efforts to carry out our business plan and transform Progressive Care from the traditional community pharmacy model to a diversified healthcare services entity are producing good results,” stated Chairman and CEO Alan Jay Weisberg.
Those attending the investor conference call will have the opportunity to submit questions concerning the Company. Question submissions shall be sent to Stuart Smith of SmallCapVoice.Com, Inc. via e-mail: ssmith@smallcapvoice.com by 12:00 PM EST on Friday, May 14, 2021. The Company will address questions that are relevant to shareholders generally and appropriate in light of public disclosure rules.
To access the call:
Dial-In Number: 1-857-232-0157 Access Code: 422095
For those unable to participate in the live conference call, a replay will be available at https://www.smallcapvoice.com/clients/rxmd/ shortly after the call has concluded.
An archived version of the webcast will also be available https://progressivecareus.com/news/.
For more information about Progressive Care, please visit the company’s website.
Connect and stay in touch with us on social media:
Hopefully only for a few more days.....
Hopefully only for a few more days.....
I'm guessing Monday the 17th we will see something for sure...just how much info is the questions. If we just show profits, which I believe we are, this will go way up. That's the confidence needed. RXMD!
Gedi- That's where my curiosity is. I know most of what is going to be coming very soon as for news, but this is interesting for sure!
I think someone is happy they bought those up!